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Obsessive compulsive disorder (OCD) has a lifetime prevalence of 1-2%. Effective treatments include cognitive behaviour therapy (CBT) and serotonin re-uptake inhibitor medication (1) but there remains a severely impaired, treatment-refractory subgroup (2) for whom anterior cingulotomy or capsulotomy is an option (3) .
Deep brain stimulation (DBS) for OCD was introduced as an alternative to neurosurgical ablation because it is reversible and adjustable (4) . Four studies have included a randomised controlled trial (RCT) of DBS at the site of the anterior capsulotomy (ventral capsule/ventral striatum, VC/VS). Earlier, small studies found that relatively few patients responded to VC/VS DBS (5, 6) but more recent, larger studies found Level 1 evidence in favour of DBS (7, 8) . Neurosurgical targeting in these studies changed over time (9) and there were also differences in the choice of DBS electrodes, all of which had four contacts at their tip but variable distances between them. It is likely that such factors led to discrepancies in the location and/or spread of stimulation and may explain the inconsistent response rates. For example, within the area of the VC/VS, it is not clear whether stimulation of capsular white matter and/or nearby grey matter provides the optimal response (7, 8) .
The anteromedial subthlamic nucleus (amSTN) is an alternative DBS target for OCD following an RCT by Mallet et al (2008) , who found significant symptomatic reduction.
Which of the two sites is better for ameliorating severe OCD has yet to be established. In addition, preliminary evidence suggests that the mechanisms of action at the two sites may differ. VC/VS DBS studies have reported a pronounced improvement in mood (5, 7, 8) not evident following the amSTN study (10) , leading Denys et al (7) to suggest that different neural circuits may mediate OCD with one stimulated by VC/VS DBS primarily improving mood and another affected by amSTN DBS primarily modulating compulsive behaviour.
In this study, using a randomised, double-blind, counterbalanced design, we investigated the effects of VC/VS and amSTN DBS in the same patients to: a) establish whether one site is more efficacious than the other in improving OCD; b) determine the precise neuroanatomical locations for optimal effects by calculating volumes of tissue activation (VTA) at each site; c) test the hypothesis of Denys et al (7) by first, employing ratings of mood and a test of cognitive flexibility previously shown to measure an M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 endophenotype of OCD (11) and second, investigating the neural circuitry associated with the DBS at each site with MRI tractography.
The potential of synergistic benefit of DBS at both sites and adjunctive cognitive behaviour therapy (CBT) was additionally explored in open phases when both DBS sites were stimulated.
METHODS AND MATERIALS

Participants
Six patients were recruited from OCD specialised services. Eligibility required: ICD10 Obsessive Compulsive Disorder; age > 20 years; illness duration > 10 years; unremitting symptoms for 2 years; Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score ≥ 32; DSM IV General Assessment of Function Scale (GAF) score ≤ 50. Patients were ineligible if pregnant or had: ICD10 substance misuse; organic brain syndrome; adult personality disorder (except obsessive-compulsive type); pervasive developmental disorder; schizophrenia or bipolar disorder; contraindications to neurosurgery. Treatment resistance was defined as: no sustained benefit from at least two serotonin reuptake inhibitors (SRI) for a minimum of 12 weeks at optimal doses, augmentation of SRI treatment with antipsychotics or by extending the SRI dose beyond recommended limits; two trials of CBT, one as inpatient, lasting 10 hours minimum. All patients provided written informed consent. The clinical trial was registered with UKCRN (13158) and ISRCTN (18430630) and received ethical approval (Clinical study: NHS HRA 12/LO/1087; MRI: NHS WLREC (10/H0706/68).
Study design (Figure S1).
Eligible participants were offered stereotactic ablation or entry to the DBS trial. Prescribed medications were kept constant unless clinically indicated. Prior to surgery, all patients underwent 3T diffusion weighted MRI for tractography analysis. Following surgery, stimulation remained off for at least 4 weeks. At the beginning of each phase, participants were admitted to a neuropsychiatry ward for two weeks for DBS adjustment. Participants remained on optimised settings for 12 weeks with a contingency for re-adjustment if
The initial two phases were double-blind, randomised and counterbalanced; each phase lasted 12 weeks. Participants received stimulation of either the anteromedial subthalamic nucleus (amSTN phase, n = 3) or the ventral capsule/ventral striatum (VC/VS phase, n = 3) followed by the alternate condition. A 12-week open phase followed during which electrodes at both sites were active (combined stimulation, COMB phase). There were two additional 12-week open phases when optimised stimulation settings were delivered using data from previous phases (OPT phase) followed by participants undergoing inpatient CBT/ERP in an inpatient unit (AdCBT phase) while continuing with the OPT DBS settings. Clinical and cognitive assessments were performed prior to surgery (baseline) and after each phase.
Neurosurgery
Surgery was performed under general anaesthesia. Patients underwent stereotactic 1.5T MRI for planning of amSTN and VC/VS coordinates and trajectories (12) . Through 14 mm frontal bilateral burr holes, 1.5 mm diameter radiofrequency electrodes were introduced to each target under dynamic impedance monitoring. These were replaced with DBS leads through the same trajectory to the target. Separate corticotomies, within the same burr hole, were used to implant the two DBS leads. Quadripolar DBS leads were used with 0.5 mm separation between contacts for amSTN leads (3389, Medtronic, Minneapolis); and 1.5 mm separation between contacts for VC/VS leads (3387, Medtronic, Minneapolis). The VC/VS lead was planned to locate one contact within the nucleus accumbens core, one within its shell and the upper two contacts in the most ventral aspect of the anterior limb of the internal capsule. An immediate stereotactic MRI verified targeting accuracy (13) . Two neurostimulators (Activa PC, Medtronic) were placed subcutaneously below the collarbone, one on each side, and each was connected to bilateral leads from one of the electrodes via subcutaneous cables.
Randomisation and blinding
Computer-generated pairwise randomization was used so that equal numbers were recruited to receive amSTN or VC/VS stimulation first, in a counterbalanced order. Two unblinded clinicians (TF, PL) held the randomization list and adjusted DBS parameters. All other team members, ward staff and participants were blind to allocation.
Stimulus adjustments
Optimal DBS parameters were derived in an iterative fashion over 2 weeks. Initially, each contact was screened with voltages up to 4V (amSTN) or 8V (VC/VS) using monopolar stimulation, pulse width 60µs and frequency 130Hz. Immediate clinical effects from stimulation delivered through each contact in turn and the threshold associated with positive and negative effects were noted. Anticipated adverse effects of stimulation included hypomania and anxiety (9, 10) and were documented with a visual analogue scale (VAS). Stimulation parameters were refined daily according to patient feedback, VAS and clinical assessment, including the use of stimulation through multiple monopolar electrode contacts per lead or using a bipolar configuration.
Clinical and cognitive assessments
The Y-BOCS was the primary outcome measure to test VC/VS and amSTN DBS effects on OCD symptoms. To test the mechanistic hypothesis, secondary measures were the Montgomery Asberg Depression Rating Scale (MADRS) to evaluate mood and the CANTAB Intra-Extra Dimensional Set Shift Task (IED) to evaluate cognitive flexibility. In the IED, participants progress through 9 stages assessing the ability to learn and reverse rules governing correct responses using computer feedback (14) . In stages 1-7 responses to a specific stimulus dimension are correct. The ability to shift attention away from the previously correct stimulus dimension to a different dimension, i.e. cognitive flexibility, is tested in the extra-dimensional set-shifting stage 8 (EDS).
Volumes of tissue activation
SureTune ® (Medtronic Inc. Minnesota), a DBS therapy planning platform, was used to model activation volumes around individual contacts. This applies neuron models coupled to finite element simulations in order to generate DBS therapy activation volumes (15) . The preprocessed post-operative MPRAGE scans were manually aligned with the pre-implantation MPRAGE scans (see Supplemental Information). Automatic co-registration was carried out with a restricted volume of fusion cantered on the mesencephalon, diencephalon and ventral striatum to minimize registration error resulting from brain shift incurred during surgery despite minimal brain shift with our surgical technique (16) . Registration accuracy Volumes corresponding to the active electrodes for each target were merged using Fslmerge (FSL v5.0) into a 4D data file for each hemisphere. Fslmaths (FSL v5.0) was then used to generate group average volumes of tissue activation.
Connectivity analysis
Pre-processed data (see Supplemental Information) were fed into BedpostX (FSL v5.0) to estimate fibre orientations. Up to three crossing fibres were estimated in each brain voxel using model 2 and graphics processing unit (GPU) parallelization (17, 18) . Probtrackx was used on these estimates to obtain global connectivity i.e. the probability of the existence of a path through the diffusion field between any two distant points, a surrogate measure of anatomical connectivity (19) . Probabilistic tractography was generated in ProbtrackX2 GPU version (FSL v5.0) (number of samples=5000, curvature -threshold=0.2, step length=0.5 mm subsidiary fibre volume fraction threshold=0.01 (19) . The process repetitively samples from the distributions of voxel-wise principal diffusion directions generated in BedpostX, each time computing a streamline through these local samples to generate a 'probabilistic streamline' or a 'sample' from the distribution on the location of the true streamline, building up a spatial 'connectivity distribution'. Streamlines truly represent paths of minimal hindrance to diffusion of water in the brain, but they are reasonable indirect estimates of long-range white matter connections (20) .
Probabilistic tractography streamlines were generated for each patient in native space. Individual patient DBS-VTAs were used as seed masks resulting in 4 tracts per patient from the amSTN and the VC/VS bilaterally. The corpus callosum was used as an exclusion
mask. CSF termination masks were used to exclude false positive streamlines. Using the obtained transformations to and from standard space, resulting streamlines were transformed to MNI space and group averages were generated. The Human Central Nervous System, A Synopsis and Atlas (second edition) was used to corroborate the relevant anatomical structures (21) .
Statistical analysis
Friedman's test was used to test for DBS effects during the double-blind cross-over phases comparing baseline, amSTN and VC/VS. Significance levels were adjusted for multiple comparisons using the false discovery rate (FDR) method of Benjamini and Hochberg (22) .
Post-hoc pair-wise Conover tests for significant effects were used (23) 
Results
Six participants were recruited from NHS England Specialised OCD Services by HT, NF, LD and KM. Five were male; the age range was 38-62yrs and the duration of illness was 20-30yrs ( Table 1) 
Comparison of VC/VS and amSTN DBS (Figure 1, Table 2)
All participants completed the IED task and the only significant DBS effect was an improvement in EDS errors. There were significant improvements in Y-BOCS, MADRS and EDS following DBS. All Friedman tests were significant controlling for FDR (Y-BOCS: Chi squared (2) = 9.0, p = 0.017; MADRS: Chi squared (2) = 10.33; p=0.017; EDS errors: Chi squared (2) = 7.00, p = 0.03). Y-BOCS scores significantly improved following both amSTN and VC/VS DBS (Baseline versus amSTN: p < 0.001; Baseline versus VC/VS: p < 0.001; amSTN versus VC/VS: p = 1.00). Changes in MADRS scores were significantly different from baseline for both amSTN and VC/VS. The magnitude of the amSTN effect was significantly greater than VC/VS (Baseline versus amSTN: p = 0.023; Baseline versus VC/VS: p < 0.001; amSTN versus VC/VS: p = 0.001). Changes in EDS errors were significant for amSTN but not VC/VS DBS (Baseline versus amSTN: p = 0.003; Baseline versus VC/VS: p = 0.157; amSTN versus VC/VS: p = 0.018). Parametric analyses substantiated these effects other than the post hoc comparison of baseline and amSTN DBS on MADRS which was not significant.
Previous studies have defined a DBS response as ≥35% reduction in baseline Y-BOCS (5) (6) (7) (8) . The proportion achieving responder status at the end of each phase was: amSTN 3/6; VC/VS 5/6; COMB 5/6; OPT 6/6; AdCBT 6/6. Tractography (Figures 3a, b) The average streamlines generated from individual amSTN VTAs were connected to the lateral orbitofrontal cortex, dorsal anterior cingulate cortex, dorsolateral prefrontal cortex and the medial forebrain bundle. The average streamlines generated from individual VC VTAs were connected to the medial orbitofrontal cortex, the mediodorsal thalamus, the amygdala via the amygdalofugal pathway, the hypothalamus and the habenula via the habenulo-interpeduncular tract. Individual patient streamlines are shown in Figure S2 (Supplemental Information).
Effects of time, combined DBS, and adjunctive CBT
Adverse events (Table S3)
There were no adverse events associated with surgery. The most common adverse event was hypomania (elevated mood or irritability, racing thoughts, disinhibition) occurring 
Discussion
This is the first study to compare, in the same patients, DBS of two brain sites for severe OCD. In a within-subjects, randomised, double-blind, counterbalanced comparison of amSTN and VC/VS stimulation in 6 patients, we were able to address important questions regarding the efficacy and mechanism of DBS at each site. All patients had been ill for at least 20 years and failed to respond to high doses of medication plus intensive CBT. DBS significantly reduced OCD symptoms during stimulation of VC/VS and amSTN and the magnitude of the reduction at each site, measured with Y-BOCS, did not differ. In contrast, there were different effects of DBS on mood and cognition. DBS of amSTN, but not VC/VS, significantly improved cognitive flexibility (EDS errors). DBS of VC/VS elicited a striking improvement in mood, measured by MADRS, which was to a greater degree than amSTN DBS. Tractography from optimally activated electrode contacts at each site suggests that these dissociated effects reflected DBS modulation of distinct brain networks.
Many studies suggest that orbitofrontal (OFC) cortico-striato-thalamic circuitry (CSTC) is dysfunctional in OCD. It is now recognized that the medial and lateral aspects occupy separate trajectories within the OFC CSTC and are functionally different (24) .
Abnormal functional connectivity between lateral OFC (Brodmann areas 10, 11, 47) and caudate nucleus is associated with EDS errors in OCD (25) . Compatible with this, amSTN DBS improves glucose metabolism in OFC (Brodmann areas 10, 11) in association with better Y-BOCS scores (26) . EDS tests the ability to adapt to changing circumstances by shifting the focus of attention and acquiring new responses, i.e. cognitive flexibility, and is a putative endophenotype of OCD being also impaired in first-degree unaffected relatives (11) . These findings are compatible with the observations of this study that amSTN DBS site was associated with improved EDS performance and that tractography streamlines from activated contacts connected to the lateral OFC.
Connectivity analysis also showed streamlines linking the dorsolateral prefrontal cortex (DLPFC) and dorsal anterior cingulate cortex (DACC) with the amSTN. In addition to the OFC, the function of these two cortical areas has been linked to the severity of OCD In non-human primates, the amSTN receives uninterrupted projections from OFC, DLPFC and DACC, considered to form the limbic and cognitive components of the hyperdirect pathway (28) . The STN is integral to basal ganglia circuitry and input from the hyperdirect pathway provides a mechanism whereby cortical influences can rapidly suppress the manifestation of behaviours that are already being programmed (29) . Taking all findings together, amSTN DBS may regulate aberrant information processing in the hyperdirect pathway from lateral OFC, DLPFC and DACC (28) and enable patients to interrupt their compulsive cycle of repetitive acts and thoughts through improving cognitive flexibility and goal-directed planning.
For all patients, the VC/VS dorsal-most electrode contacts were the most effective suggesting that stimulation of the ventral anterior limb of the internal capsule (VC), rather than the ventral striatum/nucleus accumbens, mediated the clinical effect of improved OCD and mood. This was confirmed by the volume of tissue activation, which was centred on the VC with only minor encroachment on the surrounding grey matter. Other studies support this conclusion (8, 30) .
Non-human primate tracing studies, shown to substantiate human tractography (31) , suggest that VC DBS captures fibres from medial orbitofrontal cortex (OFC) to thalamus and more posterior areas (32, 33) . This is in keeping with the tractography finding here of a streamline extending anteriorly to medial orbitofrontal cortex and posteriorly to dorsomedial thalamus, as well as streamlines involving the amygdalofugal pathway and habenulo-interpeduncular tract. The medial OFC is hyperactive during the early processing of threat related stimuli in OCD (34) . The amygdalofugal pathway is an output tract from basolateral nucleus of the amygdala to mediodorsal thalamus and OFC. A recent fMRI study of OCD found specific, abnormal connectivity between basolateral amygdala and medial-OFC in OCD which was predictive of successful treatment with cognitive behavioural therapy (35) . The habenulo-interpeduncular tract has been implicated in the development of
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13 depression via inhibition of brainstem serotonergic raphe nuclei (36) . In OCD, selective serotonin reuptake inhibitors increase serotonin neurotransmission and are the mainstay of pharmacological treatment since they improve both mood and core OCD symptoms (37) . Thus, modulation by VC DBS of circuitry involving medial OFC, associated amygdalofugal pathway, and the habenulo-interpeduncular tract may mediate the striking improvement in mood as well as OCD symptoms.
We anticipated that a positive response to DBS would enable patients to utilise CBT and boost the OCD effect further (38) but this was not found. However, inspection of individual Y-BOCS changes prior to CBT showed that 4/6 patients were already at a mild level of OCD symptom severity thus making it difficult for further measurable gains to be made during CBT.
Adverse effects were mainly stimulation-induced hypomania, also reported in other studies. These were not more common during stimulation of either site or combined stimulation.
There are several limitations to the study, the main one being the small sample size.
However, when comparing the efficacy of the two DBS sites, patients served as their own controls in an innovative design, and the conclusions were robust to adjustment for multiple comparisons and parametric and non-parametric analyses. Nevertheless it would be important to test our hypothesis in a larger group of patients when the mechanistic actions of STN and VC DBS on recovery from OCD can be evaluated in more detail. Another limitation is the possible confounding effect of combined stimulation and CBT with time.
Future studies could compare the effect of additional CBT at an earlier stage.
In summary, DBS of the VC and amSTN significantly alleviated OCD symptoms and the magnitude of effect did not differ between these sites suggesting that both targets are equally efficacious. The finding that amSTN but not VC DBS improved cognitive flexibility and that the effect of DBS on mood was significantly greater for VC DBS, implicates the involvement of different neural circuitries associated with distinct symptoms in OCD.
Tractography findings revealed that VC and amSTN DBS modulate distinct brain networks implicated in OCD and are compatible with these clinical and cognitive observations. 
Diffusion weighted 3T MRI acquisition and pre-processing
Diffusion images were acquired using Siemens' 511E Advanced Echo Planar Imaging (EPI) Diffusion WIP. In-plane acceleration was used (GRAPPA factor of 2) with partial Fourier 6/8.
In-plane resolution was 1.5×1.5 mm 2 (Field of view 219×219 mm 2 , TR = 12200 ms, TE = 99.6 ms) and 85 1.5 mm thick slices were acquired. Diffusion-weighting with b=1500 s/mm 2 was applied along 128 directions uniformly distributed on the sphere and seven b=0s volumes 
Parametric statistical analysis
Clinical and cognitive measures were checked for homogeneity of variance (Mauchly's test).
IED errors were log-transformed because of large baseline individual variability (6) . Repeated measures ANOVA was used to test DBS effects during the double-blind cross-over phases comparing baseline, amSTN and VC/VS. Significance levels were adjusted for multiple comparisons using the false discovery rate (FDR) method of Benjamini and Hochberg (7) .
Post-hoc pair-wise LSD for significant effects were corrected for the FDR. 
Supplemental Results
Parametric comparison of VC/VS and amSTN DBS
Sphericity was intact for all measures. There were significant improvements in Y-BOCS and MADRS following DBS. All participants completed the IED task and the only significant DBS effect was an improvement in EDS errors. All ANOVAs remained significant controlling for FDR (Y-BOCS: F(2,10) = 16.59, p = 0.003, d = 3.66; MADRS: F(2,10) = 4.80; p = 0.035, d = 1.96; EDS errors: F(2,10) = 6.01, p = 0.029, d = 2.19). Y-BOCS scores significantly improved following both amSTN and VC/VS DBS (Baseline versus amSTN: p = 0.020; Baseline versus VC/VS: p = 0.012; amSTN versus VC/VS: p = 0.262). Changes in MADRS scores were significant for VC/VS but not amSTN DBS (Baseline versus amSTN: p = 0.277; Baseline versus VC/VS: p = 0.051; amSTN versus VC/VS: p = 0.051). Changes in EDS errors were significant for amSTN but not VC/VS DBS (Baseline versus amSTN: p = 0.039; Baseline versus VC/VS: p = 0.741; amSTN versus VC/VS: p = 0.054). 
Parametric comparisons of the effects of time, combined DBS, and adjunctive CBT
